Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteairwaytherapeutic...
CategoryBioTech
Phone(513) 475-6613
Emailinfo@airwaytherap...
Employees

Offices

Cincinnati, USA
3130 Highland Avenue
3rd Floor
Cincinnati, OH, 45219
USA

People

President & CEO
Chief Scientific Officer

Funding

TOTAL $500k
FUNDING TOTAL $500k
Seed, 6/2011
$500k

Tags

Airway Therapeutics

Airway Therapeutics is an early stage development company that is licensing technology from within the pulmonary research program of Cincinnati Children’s Hospital Medical Center (CCHMC) for further technology platform development. This platform will enable the development of three or more products that address various market needs in the overall market for lung disorders.

A deficiency of Surfactant Protein D (SP-D) within the lungs is a major contributor to certain lung disorders. SP-D, a naturally occurring protein, is known to provide a key role in proper lung function and in protection against pulmonary infection and inflammation. The initial products for development are based on recombinant human surfactant protein D (rhSP-D), and include two products for the prevention of bronchopulmonary dysplasia (BPD) and one product for the treatment of pulmonary infections associated with cystic fibrosis (CF). Ultimately, we believe that rhSP-D can be used to treat other pulmonary infections and inflammation as well.

Recent Milestones

Videos

Screenshots

Sources

  1. Airway Therapeutics Tracking Down $1.2M For Pulmonary Therapy (fis.dowjones.com) [edit]
Edit This Page
Last Edited 3/18/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy